Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-BWWD for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 33 adverse event reports in the FDA FAERS database where ADALIMUMAB-BWWD was used for Psoriasis.

Most Reported Side Effects for ADALIMUMAB-BWWD

Side Effect Reports % Deaths Hosp.
Injection site pain 95 13.1% 0 6
Off label use 64 8.9% 1 20
Drug ineffective 60 8.3% 0 15
Fatigue 48 6.6% 0 14
Arthralgia 46 6.4% 0 10
Device issue 42 5.8% 0 3
Rheumatoid arthritis 42 5.8% 0 5
Product substitution issue 40 5.5% 0 2
Accidental exposure to product 37 5.1% 0 2
Exposure via skin contact 34 4.7% 0 2
Pain 34 4.7% 2 9
Headache 32 4.4% 0 7
Rash 32 4.4% 0 5
Wrong technique in product usage process 32 4.4% 0 1
Injection site bruising 31 4.3% 0 2

Other Indications for ADALIMUMAB-BWWD

Rheumatoid arthritis (174) Crohn's disease (134) Product used for unknown indication (94) Psoriatic arthropathy (78) Ankylosing spondylitis (62) Hidradenitis (37) Uveitis (37) Colitis ulcerative (32) Sarcoidosis (7) Arthritis (6)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

ADALIMUMAB-BWWD Full Profile All Psoriasis Drugs ADALIMUMAB-BWWD Demographics ADALIMUMAB-BWWD Timeline